Literature DB >> 21929451

Therapeutic compliance of nanomedicine in Alzheimer's disease.

Barnabas Wilson.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21929451     DOI： 10.2217/nnm.11.114

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN： 1743-5889            Impact factor:   5.307


× No keyword cloud information.
  2 in total

Review 1.  Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.

Authors:  Hitesh Chopra; Shabana Bibi; Inderbir Singh; Mohammad Amjad Kamal; Fahadul Islam; Fahad A Alhumaydhi; Talha Bin Emran; Simona Cavalu
Journal:  Front Aging Neurosci       Date:  2022-07-08       Impact factor: 5.702

2.  Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model.

Authors:  Sabrina Meister; Iavor Zlatev; Julia Stab; Dominic Docter; Sandra Baches; Roland H Stauber; Mordechai Deutsch; Reinhold Schmidt; Stefan Ropele; Manfred Windisch; Klaus Langer; Sylvia Wagner; Hagen von Briesen; Sascha Weggen; Claus U Pietrzik
Journal:  Alzheimers Res Ther       Date:  2013-11-27       Impact factor: 6.982
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.